title: Lorcaserin, dimethyl fumarate, and bedaquiline fumarate.
authors.affiliation: Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, PA. USA.
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Hussar
authors.forename: Georgiy
authors.initials: G
authors.lastname: Polyak
mesh_terms: D019440:Anti-Obesity Agents / Q000009:adverse effects / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D001552:Benzazepines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D064687:Diarylquinolines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D000069462:Dimethyl Fumarate; D005650:Fumarates / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000188:drug therapy / Q000503:physiopathology; D009765:Obesity / Q000188:drug therapy / Q000503:physiopathology; D014376:Tuberculosis / Q000188:drug therapy / Q000382:microbiology
chemical_list: D019440:Anti-Obesity Agents; D000995:Antitubercular Agents; D001552:Benzazepines; D064687:Diarylquinolines; D005650:Fumarates; D007166:Immunosuppressive Agents; C506658:lorcaserin; C493870:bedaquiline; D000069462:Dimethyl Fumarate